Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Detection of red cell sensitisation by antibody and complement: Current practice and future perspectives

Detection of red cell sensitisation by antibody and complement: Current practice and future... In autoimmune haemolytic anaemia (AHA) antibody(ies) are directed at ‘self’ red blood cells (RBC) and can effect their destruction. This removal of RBC may be enhanced by the additional presence of complement on the cell membrane. The diagnosis of AHA requires the demonstration of such antibody(ies), which are able to sensitise autologous erythrocytes in vivo. AHA has been described in a variety of animal species but the techniques employed in the laboratory diagnosis have, generally, been extrapolated from those used in human serology. The application of newer and more sensitive techniques to the assessment of RBC sensitisation with antibody and complement, has improved the diagnosis of AHA. Furthermore, it is now possible to assess the significance of the degree of RBC sensitisation and to evaluate treatment regimens. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Comparative Clinical Pathology Springer Journals

Detection of red cell sensitisation by antibody and complement: Current practice and future perspectives

Comparative Clinical Pathology , Volume 3 (4) – Feb 20, 2006

Loading next page...
 
/lp/springer-journals/detection-of-red-cell-sensitisation-by-antibody-and-complement-current-CpkN0AMahE

References (166)

Publisher
Springer Journals
Copyright
Copyright © 1993 by Springer-Verlag
Subject
Medicine & Public Health; Pathology; Hematology; Oncology
eISSN
1433-2973
DOI
10.1007/BF02341967
Publisher site
See Article on Publisher Site

Abstract

In autoimmune haemolytic anaemia (AHA) antibody(ies) are directed at ‘self’ red blood cells (RBC) and can effect their destruction. This removal of RBC may be enhanced by the additional presence of complement on the cell membrane. The diagnosis of AHA requires the demonstration of such antibody(ies), which are able to sensitise autologous erythrocytes in vivo. AHA has been described in a variety of animal species but the techniques employed in the laboratory diagnosis have, generally, been extrapolated from those used in human serology. The application of newer and more sensitive techniques to the assessment of RBC sensitisation with antibody and complement, has improved the diagnosis of AHA. Furthermore, it is now possible to assess the significance of the degree of RBC sensitisation and to evaluate treatment regimens.

Journal

Comparative Clinical PathologySpringer Journals

Published: Feb 20, 2006

There are no references for this article.